ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "stress"

  • Abstract Number: 0093 • ACR Convergence 2021

    The Association of General and Covid-19-Specific Stress with Changes in Patient-Reported Outcomes and Comorbidities

    Patricia Katz1, Kristin Wipfler2, Sofia Pedro3 and Kaleb Michaud4, 1University of California San Francisco, San Francisco, CA, 2FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 3Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 4University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: We previously showed that perceived stress during the COVID-19 pandemic was associated with concomitant increases in symptoms of depression and anxiety. In lupus alone,…
  • Abstract Number: 1824 • 2019 ACR/ARP Annual Meeting

    Perceived Stress Independently Associates with Worse Type 2 Symptoms in Systemic Lupus Erythematosus

    Sarah Patterson1, Laura Trupin 1, Cristina Lanata 1, Louise Murphy 2, Wendy Hartogenesis 1, Maria Dall'Era 1, Jinoos Yazdany 3 and Patricia Katz 1, 1University of California, San Francisco, San Francisco, CA, 2Centers for Disease Control and Prevention, Division of Population Health, Atlanta, 3UCSF Division of Rheumatology, San Francisco, CA

    Background/Purpose: A new posited framework for categorizing patients with systemic lupus erythematosus (SLE) is the division of symptomatology into two groups: type 1 manifestations represent…
  • Abstract Number: 2269 • 2019 ACR/ARP Annual Meeting

    Major Stressors in the Year Prior to Diagnosis Affects RA Characteristics at Presentation and 1 Year

    Nicole Andersen1, Orit Schieir 2, Marie-France Valois 3, Gilles Boire 4, Janet Pope 5, Glen Hazlewood 6, Louis Bessette 7, Carol Hitchon 8, Diane Tin 9, Carter Thorne 10, Edward Keystone 11, Vivian Bykerk 12, Susan J. Bartlett 1 and Canadian Early Arthritis Cohort (CATCH) Investigators 13, 1McGill University, Montreal, QC, Canada, 2University of Toronto, Montreal, Canada, 3McGill University, Montreal, Canada, 4Sherbrooke University, Sherbrooke, QC, Canada, 5Western University, London, ON, Canada, 6University of Calgary, Calgary, Canada, 7Laval University, Quebec City, QC, Canada, 8University of Manitoba, Winnipeg, Canada, 9Southlake Regional Health Centre, Newmarket, Canada, 10Southlake Regional Health Centre, Newmarket, ON, Canada, 11Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, 12Hospital for Special Surgery, New York City, NY, 13Canadian Early Arthritis Cohort (CATCH) Study, Toronto, Canada

    Background/Purpose: Although many RA patients attribute their disease onset to recent life events, results from retrospective studies remain unclear. We compared characteristics of newly diagnosed…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology